Enhancing adherence of antihypertensive regimens in hypertensive African-Americans: Current and future prospects

Expert Review of Cardiovascular Therapy

Volumn 10, Issue 11, 2012, Pages 1375-1380

  Lewis, Lisa M ^a   Ogedegbe, Chinwe ^b   Ogedegbe, Gbenga ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African American; cardiovascular; disparities; hypertension; medication adherence

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AFRICAN AMERICAN; CAUCASIAN; DEPRESSION; DOCTOR PATIENT RELATION; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; PATIENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; RACE DIFFERENCE; REVIEW; SELF CONCEPT;

AFRICAN AMERICANS; ANTIHYPERTENSIVE AGENTS; DEPRESSION; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS DISPARITIES; HUMANS; HYPERTENSION; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC; SELF EFFICACY; UNITED STATES;

EID: 84871277975     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.12.138     Document Type: Review

References (49)

1. Roger VL, Go AS, Lloyd-Jones DM et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123(4), e18-e209 (2011).
2. Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann. Fam. Med. 6(6), 497-502 (2008).
3. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N. Engl. J. Med. 347(20), 1585-1592 (2002).
4. IOM. A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension. The National Academies Press, Washington, DC (2010).
5. Dragomir A, Côté R, Roy L et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med. Care 48(5), 418-425 (2010).
6. Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J. Clin. Hypertens. (Greenwich). 11(7), 376-382 (2009).
7. Roebuck MC, Liberman JN, Gemmill- Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. (Millwood) 30(1), 91-99 (2011).
8. Osterberg L, Blaschke T. Adherence to medication. N. Engl. J. Med. 353(5), 487-497 (2005).
9. Sabate E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, Geneva, Switzerland (2003).
10. Bosworth HB, Dudley T, Olsen MK et al. Racial differences in blood pressure control: potential explanatory factors. Am. J. Med. 119(1), 70.e79-70.e15 (2006)
11. Charles H, Good CB, Hanusa BH, Chang CC, Whittle J. Racial differences in adherence to cardiac medications. J. Natl Med. Assoc. 95(1), 17-27 (2003).
12. Krousel-Wood MA, Muntner P, Joyce CJ et al. Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J. Am. Geriatr. Soc. 58(1), 54-61 (2010).
13. Ndumele CD, Shaykevich S, Williams D, Hicks LS. Disparities in adherence to hypertensive care in urban ambulatory settings. J. Health Care Poor Underserved 21(1), 132-143 (2010).
14. Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population. J. Natl Med. Assoc. 101(1), 34-39 (2009).
15. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am. J. Med. 120(1), 26-32 (2007).
16. Nazroo J, Jackson J, Karlsen S, Torres M. The Black diaspora and health inequalities in the US and England: does where you go and how you get there make a difference? Sociol. Health Illn. 29(6), 811-830 (2007).
17. Poon I, Lal LS, Ford ME, Braun UK. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Ann. Pharmacother. 43(2), 185-193 (2009).
18. Lewis LM, Askie P, Randleman S, Shelton-Dunston B. Medication adherence beliefs of community-dwelling hypertensive African-Americans. J. Cardiovasc. Nurs. 25(3), 199-206 (2010).
19. Martins D, Gor D, Teklehaimanot S, Norris K. High blood pressure knowledge in an urban African-American community. Ethn. Dis. 11(1), 90-96 (2001).
20. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. The National Academies Press, Washington, DC (2002).
21. Braverman J, Dedier J. Predictors of medication adherence for African-American patients diagnosed with hypertension. Ethn. Dis. 19(4), 396-400 (2009).
22. Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn. Dis. 14(1), 3-12 (2004).
23. Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ. Behav. 36(1), 127-137 (2009).
24. Fongwa MN, Evangelista LS, Hays RD et al. Adherence treatment factors in hypertensive African-American women. Vasc. Health Risk Manag. 4(1), 157-166 (2008).
25. Rose LE, Kim MT, Dennison CR, Hill MN. The contexts of adherence for African-Americans with high blood pressure. J. Adv. Nurs. 32(3), 587-594 (2000).
26. Hill MN, Bone LR, Kim MT, Miller DJ, Dennison CR, Levine DM. Barriers to hypertension care and control in young urban black men. Am. J. Hypertens. 12(10 Pt 1), 951-958 (1999).
27. Turner BJ, Hollenbeak C, Weiner MG, Ten Have T, Roberts C. Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol. Drug Saf. 18(8), 672-681 (2009).
28. Bogner HR, Cary MS, Bruce ML et al. The role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study. Am. J. Geriatr. Psychiatry 13(10), 861-868 (2005).
29. Kim MT, Han HR, Hill MN, Rose L, Roary M. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann. Behav. Med. 26(1), 24-31 (2003).
30. Schoenthaler A, Chaplin WF, Allegrante JP et al. Provider communication effects medication adherence in hypertensive African-Americans. Patient Educ. Couns. 75(2), 185-191 (2009).
31. Hekler EB, Lambert J, Leventhal E, Leventhal H, Jahn E, Contrada RJ. Commonsense illness beliefs, adherence behaviors, and hypertension control among African-Americans. J. Behav. Med. 31(5), 391-400 (2008).
32. Lagu T, Weiner MG, Eachus S, Tang SS, Schwartz JS, Turner BJ. Effect of patient comorbidities on filling of antihypertensive prescriptions. Am. J. Manag. Care 15(1), 24-30 (2009).
33. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am. J. Public Health 82(12), 1607-1612 (1992).
34. Lukoschek P. African-Americans' beliefs and attitudes regarding hypertension and its treatment: a qualitative study. J. Health Care Poor Underserved 14(4), 566-587 (2003).
35. Martin MY, Kohler C, Kim YI et al. Taking less than prescribed: medication nonadherence and provider-patient relationships in lower-income, rural minority adults with hypertension. J. Clin. Hypertens. (Greenwich) 12(9), 706-713 (2010).
36. Trivedi AN, Ayanian JZ. Perceived discrimination and use of preventive health services. J. Gen. Intern. Med. 21(6), 553-558 (2006).
37. Brondolo E, Libby DJ, Denton EG et al. Racism and ambulatory blood pressure in a community sample. Psychosom. Med. 70(1), 49-56 (2008).
38. Lewis TT, Barnes LL, Bienias JL, Lackland DT, Evans DA, Mendes de Leon CF. Perceived discrimination and blood pressure in older African-American and white adults. J. Gerontol. A Biol. Sci. Med. Sci. 64(9), 1002-1008 (2009).
39. Peters RM. Racism and hypertension among African-Americans. West. J. Nurs. Res. 26(6), 612-631 (2004).
40. Roberts CB, Vines AI, Kaufman JS, James SA. Cross-sectional association between perceived discrimination and hypertension in African-American men and women: the Pitt County Study. Am. J. Epidemiol. 167(5), 624-632 (2008).
41. Williams DR, González HM, Neighbors H et al. Prevalence and distribution of major depressive disorder in African-Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. Arch. Gen. Psychiatry 64(3), 305-315 (2007).
42. Bailey RK, Blackmon HL, Stevens FL. Major depressive disorder in the African-American population: meeting the challenges of stigma, misdiagnosis, and treatment disparities. J. Natl Med. Assoc. 101(11), 1084-1089 (2009).
43. Miranda J, Cooper LA. Disparities in care for depression among primary care patients. J. Gen. Intern. Med. 19(2), 120-126 (2004).
44. Krousel-Wood M, Hyre A, Muntner P, Morisky D. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr. Opin. Cardiol. 20(4), 296-300 (2005).
45. Ogedegbe G, Chaplin W, Schoenthaler A et al. A practice-based trial of motivational interviewing and adherence in hypertensive African-Americans. Am. J. Hypertens. 21(10), 1137-1143 (2008).
46. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch. Intern. Med. 164(7), 722-732 (2004).
47. Odedosu T, Schoenthaler A, Vieira DL, Agyemang C, Ogedegbe G. Overcoming barriers to hypertension control in African-Americans. Cleve. Clin. J. Med. 79(1), 46-56 (2012).
48. Ogedegbe GO, Boutin-Foster C, Wells MT et al. A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans. Arch. Intern. Med. 172(4), 322-326 (2012).
49. Pittman DG, Tao Z, Chen W, Stettin GD. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am. J. Manag. Care 16(8), 568-576 (2010).